249 related articles for article (PubMed ID: 19207948)
1. DMBT1 expression distinguishes anorectal from cutaneous melanoma.
Helmke BM; Renner M; Poustka A; Schirmacher P; Mollenhauer J; Kern MA
Histopathology; 2009 Jan; 54(2):233-40. PubMed ID: 19207948
[TBL] [Abstract][Full Text] [Related]
2. Her2 overexpression is a rare event in anorectal melanoma.
Helmke BM; Zahel T; Breinig M; Schirmacher P; Aulmann S; Kern MA
Melanoma Res; 2010 Oct; 20(5):431-4. PubMed ID: 20562656
[TBL] [Abstract][Full Text] [Related]
3. HMB-45 and Melan-A are useful in the differential diagnosis between granular cell tumor and malignant melanoma.
Gleason BC; Nascimento AF
Am J Dermatopathol; 2007 Feb; 29(1):22-7. PubMed ID: 17284958
[TBL] [Abstract][Full Text] [Related]
4. Malignant melanoma with neuroendocrine differentiation: clinical, histological, immunohistochemical and ultrastructural features of three cases.
Eyden B; Pandit D; Banerjee SS
Histopathology; 2005 Oct; 47(4):402-9. PubMed ID: 16178895
[TBL] [Abstract][Full Text] [Related]
5. DMBT1 is frequently downregulated in well-differentiated gastric carcinoma but more frequently upregulated across various gastric cancer types.
Conde AR; Martins AP; Brito M; Manuel A; Ramos S; Malta-Vacas J; Renner M; Poustka A; Mollenhauer J; Monteiro C
Int J Oncol; 2007 Jun; 30(6):1441-6. PubMed ID: 17487364
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of heat shock protein 105 in melanoma and melanocytic naevi.
Muchemwa FC; Nakatsura T; Fukushima S; Nishimura Y; Kageshita T; Ihn H
Melanoma Res; 2008 Jun; 18(3):166-71. PubMed ID: 18477890
[TBL] [Abstract][Full Text] [Related]
7. Anorectal malignant melanoma: morphologic and immunohistochemical features.
Chute DJ; Cousar JB; Mills SE
Am J Clin Pathol; 2006 Jul; 126(1):93-100. PubMed ID: 16753594
[TBL] [Abstract][Full Text] [Related]
8. Primary amelanotic anorectal melanoma: an uncommon neoplasia with poor prognosis.
Khaled A; Hammami H; Fazaa B; Kourda N; Kamoun MR; Ben Jilany S; Zoghlami A
Pathologica; 2009 Jun; 101(3):126-9. PubMed ID: 19886548
[TBL] [Abstract][Full Text] [Related]
9. BRAF mutations distinguish anorectal from cutaneous melanoma at the molecular level.
Helmke BM; Mollenhauer J; Herold-Mende C; Benner A; Thome M; Gassler N; Wahl W; Lyer S; Poustka A; Otto HF; Deichmann M
Gastroenterology; 2004 Dec; 127(6):1815-20. PubMed ID: 15578519
[TBL] [Abstract][Full Text] [Related]
10. HMB-45 may be a more sensitive maker than S-100 or Melan-A for immunohistochemical diagnosis of primary oral and nasal mucosal melanomas.
Yu CH; Chen HH; Liu CM; Jeng YM; Wang JT; Wang YP; Liu BY; Sun A; Chiang CP
J Oral Pathol Med; 2005 Oct; 34(9):540-5. PubMed ID: 16138892
[TBL] [Abstract][Full Text] [Related]
11. Expression of heat shock protein 105 and 70 in malignant melanoma and benign melanocytic nevi.
Park HS; Park CH; Choi BR; Lim MS; Heo SH; Kim CH; Kang SG; Whang KU; Cho MK
J Cutan Pathol; 2009 May; 36(5):511-6. PubMed ID: 19476517
[TBL] [Abstract][Full Text] [Related]
12. WT1 as a complementary marker of malignant melanoma: an immunohistochemical study of whole sections.
Wilsher M; Cheerala B
Histopathology; 2007 Nov; 51(5):605-10. PubMed ID: 17927581
[TBL] [Abstract][Full Text] [Related]
13. Dermatopathological indicators of poor melanoma prognosis are significantly inversely correlated with the expression of NM23 protein in primary cutaneous melanoma.
Ferrari D; Lombardi M; Ricci R; Michiara M; Santini M; De Panfilis G
J Cutan Pathol; 2007 Sep; 34(9):705-12. PubMed ID: 17696918
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical aid at risk stratification of melanocytic neoplasms.
Quatresooz P; Arrese JE; Pierard-Franchimont C; Pierard GE
Int J Oncol; 2004 Jan; 24(1):211-6. PubMed ID: 14654959
[TBL] [Abstract][Full Text] [Related]
15. PNL2 melanocytic marker in immunohistochemical evaluation of primary mucosal melanoma of the head and neck.
Morris LG; Wen YH; Nonaka D; DeLacure MD; Kutler DI; Huan Y; Wang BY
Head Neck; 2008 Jun; 30(6):771-5. PubMed ID: 18228523
[TBL] [Abstract][Full Text] [Related]
16. Melanoma or not? Cancer testis antigens may help.
Lüftl M; Schuler G; Jungbluth AA
Br J Dermatol; 2004 Dec; 151(6):1213-8. PubMed ID: 15606517
[TBL] [Abstract][Full Text] [Related]
17. SOX10 immunostaining distinguishes desmoplastic melanoma from excision scar.
Ramos-Herberth FI; Karamchandani J; Kim J; Dadras SS
J Cutan Pathol; 2010 Sep; 37(9):944-52. PubMed ID: 20653825
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of combined h-TERT, bcl-2, and caspases 3 and 8 expression in cutaneous malignant melanoma based on tissue microarrays and computerized image analysis.
Zygouris P; Tsiambas E; Tiniakos D; Karameris A; Athanassiou AE; Kittas Ch; Kyroudi A
J BUON; 2007; 12(4):513-9. PubMed ID: 18067210
[TBL] [Abstract][Full Text] [Related]
19. Tumor characteristics involved in the metastatic behaviour as an improvement in primary cutaneous melanoma prognostics.
Goldmann T; Ribbert D; Suter L; Brode M; Otto F
J Exp Clin Cancer Res; 1998 Dec; 17(4):483-9. PubMed ID: 10089072
[TBL] [Abstract][Full Text] [Related]
20. Clusterin expression in primary and metastatic melanoma.
Busam KJ; Kucukgol D; Eastlake-Wade S; Frosina D; Delgado R; Jungbluth AA
J Cutan Pathol; 2006 Sep; 33(9):619-23. PubMed ID: 16965336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]